A 3-day low-fibre diet does not improve colonoscopy preparation results compared to a 1-day diet: A randomized, single-blind, controlled trial.


Journal

United European gastroenterology journal
ISSN: 2050-6414
Titre abrégé: United European Gastroenterol J
Pays: England
ID NLM: 101606807

Informations de publication

Date de publication:
12 2019
Historique:
received: 05 08 2019
accepted: 24 09 2019
entrez: 17 12 2019
pubmed: 17 12 2019
medline: 1 7 2020
Statut: ppublish

Résumé

Although a 1-day low-fibre diet before colonoscopy is currently recommended, some endoscopists prescribe a 3-day diet. The objective of this study was to compare the influence of a 3-day versus a 1-day low-fibre diet on bowel preparation quality, patient tolerability and adherence. Outpatients scheduled for total colonoscopy were randomized in two groups, 3-day versus 1-day low-fibre diet, performing a 4-litre polyethylene glycol split-dose. The primary outcome was a reduction of inappropriate preparations in the 3-day low-fibre diet arm from 15% to 5% (bowel preparation was assessed by the Boston Bowel Preparation Scale). Secondary outcomes were adherence to, difficulty to perform, difficulty to obtain and willingness to repeat the diet. Intention-to-treat (ITT) and per-protocol (PP) analyses were conducted for the primary outcome. A total of 412 patients were randomized (206 per group). Bowel preparation quality was similar between groups. On ITT analysis ( A 3-day low-fibre diet does not bring benefit to the bowel preparation quality and is harder to perform than a 1-day diet.

Sections du résumé

Background
Although a 1-day low-fibre diet before colonoscopy is currently recommended, some endoscopists prescribe a 3-day diet.
Objective
The objective of this study was to compare the influence of a 3-day versus a 1-day low-fibre diet on bowel preparation quality, patient tolerability and adherence.
Methods
Outpatients scheduled for total colonoscopy were randomized in two groups, 3-day versus 1-day low-fibre diet, performing a 4-litre polyethylene glycol split-dose. The primary outcome was a reduction of inappropriate preparations in the 3-day low-fibre diet arm from 15% to 5% (bowel preparation was assessed by the Boston Bowel Preparation Scale). Secondary outcomes were adherence to, difficulty to perform, difficulty to obtain and willingness to repeat the diet. Intention-to-treat (ITT) and per-protocol (PP) analyses were conducted for the primary outcome.
Results
A total of 412 patients were randomized (206 per group). Bowel preparation quality was similar between groups. On ITT analysis (
Conclusion
A 3-day low-fibre diet does not bring benefit to the bowel preparation quality and is harder to perform than a 1-day diet.

Identifiants

pubmed: 31839957
doi: 10.1177/2050640619883176
pii: 10.1177_2050640619883176
pmc: PMC6893996
doi:

Substances chimiques

Dietary Fiber 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1321-1329

Informations de copyright

© Author(s) 2019.

Références

Gastrointest Endosc. 2016 Mar;83(3):499-507.e1
pubmed: 26460222
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Gastrointest Endosc. 2010 Oct;72(4):686-92
pubmed: 20883845
Gastroenterol Hepatol. 2019 May;42(5):326-338
pubmed: 31027972
Adv Nutr. 2015 Nov 13;6(6):820-7
pubmed: 26567203
Gastrointest Endosc. 2015 Apr;81(4):781-94
pubmed: 25595062
Gastrointest Endosc. 2014 Oct;80(4):566-576.e2
pubmed: 25053529
Endoscopy. 2019 Jul;51(7):628-636
pubmed: 30943553
Gastrointest Endosc. 2015 Jan;81(1):31-53
pubmed: 25480100
Gastrointest Endosc. 2018 Oct;88(4):685-694
pubmed: 30220301
Endoscopy. 2017 Apr;49(4):378-397
pubmed: 28268235
GE Port J Gastroenterol. 2017 Jan;24(1):22-30
pubmed: 28848777
Am J Gastroenterol. 2013 May;108(5):718-27
pubmed: 23545709
Clin Gastroenterol Hepatol. 2018 Mar;16(3):357-369.e10
pubmed: 28826680
Endoscopy. 2013;45(2):142-50
pubmed: 23335011
Eur J Gastroenterol Hepatol. 2018 Aug;30(8):819-826
pubmed: 29847488
Medicine (Baltimore). 2016 Jan;95(1):e2432
pubmed: 26735547
Gastrointest Endosc Clin N Am. 2015 Apr;25(2):183-97
pubmed: 25839681
Arch Gynecol Obstet. 2009 Nov;280(5):713-8
pubmed: 19229545
United European Gastroenterol J. 2014 Feb;2(1):22-9
pubmed: 24918005

Auteurs

Filipe Taveira (F)

Department of Gastroenterology, Portuguese Oncology Institute of Coimbra, Coimbra, Portugal.

Miguel Areia (M)

Department of Gastroenterology, Portuguese Oncology Institute of Coimbra, Coimbra, Portugal.
Center for Health Technology and Services Research (CINTESIS), Faculty of Medicine, University of Porto, Porto, Portugal.

Luís Elvas (L)

Department of Gastroenterology, Portuguese Oncology Institute of Coimbra, Coimbra, Portugal.

Susana Alves (S)

Department of Gastroenterology, Portuguese Oncology Institute of Coimbra, Coimbra, Portugal.

Daniel Brito (D)

Department of Gastroenterology, Portuguese Oncology Institute of Coimbra, Coimbra, Portugal.

Sandra Saraiva (S)

Department of Gastroenterology, Portuguese Oncology Institute of Coimbra, Coimbra, Portugal.

Ana T Cadime (AT)

Department of Gastroenterology, Portuguese Oncology Institute of Coimbra, Coimbra, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH